Proven clinical stage IIIA-nonsmall cell lung cancer |
Cytological or histological proof of N2 disease |
Uni- or bi-dimensional measurable tumour |
Irresectable N2 disease |
No symptomatic central nervous system involvement |
No prior chemotherapy or radiotherapy |
No other malignancies |
Informed consent |